Tekla Capital Management LLC Ovid Therapeutics Inc. Transaction History

Tekla Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.31 - $4.04 $1.23 Million - $1.51 Million	-372,733 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $197,547 - $265,882	-124,244 Reduced 25.0%	372,733 $690,000
Q4 2018 Feb 13, 2019	SELL	$2.42 - $6.6 $94,009 - $256,390	-38,847 Reduced 7.25%	496,977 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$6.12 - $12.31 $2.28 Million - $4.6 Million	373,287 Added 229.66%	535,824 $5.29 Million
Q3 2017 Nov 13, 2017	SELL	$5.32 - $9.77 $1.99 Million - $3.65 Million	-373,287 Reduced 69.67%	162,537 $1.39 Million

Q2 2017 Aug 14, 2017	BUY	N/A	535,824	535,824 $5.23 Million

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $59.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.